Raloxifene Hydrochloride

Product NDC
70518-3046
11-digit product format
705183046
Labeler code
70518
Product ID
70518-3046_bd49f44e-0e2b-8671-e053-2a95a90addc8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Raloxifene
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA090842
Marketing category
ANDA
Marketing start
2021-03-11
Marketing end
0000-00-00
Substance
RALOXIFENE HYDROCHLORIDE
Active strength
60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3046-02023-03-15C16284748780-1f386c64a-2929-0266-e053-dadaa90a7c1a5ddadc82-e0de-408f-aed7-283ec25c427e
70518-3046-02023-01-30C16284748780-1f386c64a-2929-0266-e053-dadaa90a7c1a5ddadc82-e0de-408f-aed7-283ec25c427e

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3046-07051830460030 POUCH in 1 BOX (70518-3046-0) > 1 TABLET in 1 POUCH (70518-3046-1) 30 pouch2021-03-110000-00-00NoNoCurrent